AMANDA SEEGOBIN: Open Payments
NPI 1720539703 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 74 payments from 22 companies in 2025. Trend: 2023 $956 · 2024 $1,216 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $305 |
| PFIZER INC. | 17 | $290 |
| ABBVIE INC. | 11 | $263 |
| ARGENX US, INC. | 5 | $98 |
| JAZZ PHARMACEUTICALS INC. | 3 | $59 |
| UCB, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $56 |
| MDD US Operations, LLC | 3 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
Products named: PONVORY, NURTEC ODT, QULIPTA, UBRELVY, PANZYGA, XYWAV, VYVGART HYTRULO, Gocovri.
Industry payments across FL — which companies pay providers there.
